Patent for Reducing Inflammatory Response Granted to Galectin Therapeutics

NORCROSS, Ga., June 21, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has received notice of allowance for a U.S. Patent for "Galacto-Rhamnogalacturonate compositions for the treatment of a number of diseases associated with elevated inducible nitric … [Read more...]

Olainfarm will hold First Quarter 2017 Investor Conference Webinar

Olaine, 2017-06-20 15:32 CEST (GLOBE NEWSWIRE) -- presentation will be held in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyze the financial results of the first quarter 2017. After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance … [Read more...]

The Jackson Laboratory and Crown Bioscience Announce Global Pre-Clinical Research Agreement

BAR HARBOR, Maine and SANTA CLARA, Calif., June 20, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience (CrownBio), a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), and The Jackson Laboratory (JAX) today announced an agreement to improve the development and accessibility of innovative research models and pre-clinical services to the global biomedical … [Read more...]